SteriPlas destroys bacteria1 standard therapies can’t, breaking the cycle of infection and accelerating recovery.2,3
Stuck in a cycle of chronic wound infection?
Poor circulation, fragile tissue, and irregular wound beds allow infection to persist in conditions such as diabetic foot, pressure, and vascular ulcers.4
When healing stalls, risks escalate
Chronic infection prolongs recovery, increases antibiotic use, and heightens the risk of serious complications, from repeated hospitalisation to amputation.4
Standard therapies fail, allowing chronic wound infections to persist
Despite best practice, many wound infection therapies can’t reach or destroy bacteria deep within the wound.
Systemic antibiotics can’t reach poorly perfused tissue effectively5,6
Topical therapies struggle to penetrate biofilm or irregular wound surfaces5
Debridement is invasive and can cause additional tissue trauma
Break the cycle with
SteriPlas Premium Cold Plasma clears infection at its source.
Flowing across irregular wound surfaces, the plasma penetrates deep into tissue and biofilm to destroy resistant bacteria,1 without harming healthy cells.7
It’s precise, painless, and proven to accelerate healing2,3 when other therapies fall short.
Reduces bacterial load by 73.5%1
Decreases would size and depth by up to 100%8
Consistently outperforms antibiotics1
Discover SteriPlas
Getting started is simple
01
Speak to a representative to check eligibility
Meet with our team and check if you’re eligible to evaluate.
02
Start a fully supported evaluation
Get full training, clinical support, and outcome tracking throughout.
03
Choose to lease or buy
Decide on the best funding route for your hospital.
Clinically proven to clear infection
References
1. Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410. doi:10.1111/j.1365-2133.2012.10923.x
2. Isbary G, Stolz W, Shimizu T, et al. Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: Results of an open retrospective randomized controlled study in vivo. Clin Plasma Med. 2013;1(2):25-30. doi:10.1016/j.cpme.2013.06.001
3. Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc. 2013;21(6):800-807. doi:10.1111/wrr.12078
4. Wolny D, Štěpánek L, Horáková D, Thomas J, Zapletalová J, Patel MS. Risk Factors for Non-Healing Wounds—A Single-Centre Study. J Clin Med. 2024;13(4):1003. doi:10.3390/jcm13041003
5. Jager NGL, van Hest RM, Lipman J, Roberts JA, Cotta MO. Antibiotic exposure at the site of infection: principles and assessment of tissue penetration. Expert Rev Clin Pharmacol. 2019;12(7):623-634. doi:10.1080/17512433.2019.1621161
6. Stuermer EK, Plattfaut I, Dietrich M, et al. In vitro Activity of Antimicrobial Wound Dressings on P. aeruginosa Wound Biofilm. Front Microbiol. 2021;12. doi:10.3389/fmicb.2021.664030
7. Heinlin J, Isbary G, Stolz W, et al. Plasma applications in medicine with a special focus on dermatology: Plasma medicine. J Eur Acad Dermatol Venereol. 2011;25(1):1-11. doi:10.1111/j.1468-3083.2010.03702.x
8. Moelleken M, Jockenhöfer F, Wiegand C, Buer J, Benson S, Dissemond J. Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2020;18(10):1094-1101. doi:10.1111/ddg.14294